2006
DOI: 10.1016/j.ejogrb.2005.10.010
|View full text |Cite
|
Sign up to set email alerts
|

Effect of the cessation of long-term hormone replacement therapy on plasma plasminogen activator inhibitor-1 and fibrinogen

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2008
2008
2017
2017

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 30 publications
0
1
0
Order By: Relevance
“…However, these effects and the blood concentrations of respective hormones differ between different types of HRT and routes of administration, and they disappear rapidly after discontinuation of HRT 1011 12 13 14 15 16 17 Discontinuation of HRT can be troublesome owing to rebound climacteric symptoms, and this is particularly problematic in women diagnosed as having coronary artery disease while using HRT, as guidelines for this situation recommend discontinuation of HRT although evidence on the risk-benefit of this strategy is lacking 1819 20 21 Indeed, the period after a myocardial infarction is a pathophysiologically vulnerable time, with endothelial dysfunction, elevated inflammatory markers, and so on, and potential rebound effects on these mechanisms of discontinuation of HRT may be more prone to cause adverse cardiovascular events in this period 22…”
Section: Introductionmentioning
confidence: 99%
“…However, these effects and the blood concentrations of respective hormones differ between different types of HRT and routes of administration, and they disappear rapidly after discontinuation of HRT 1011 12 13 14 15 16 17 Discontinuation of HRT can be troublesome owing to rebound climacteric symptoms, and this is particularly problematic in women diagnosed as having coronary artery disease while using HRT, as guidelines for this situation recommend discontinuation of HRT although evidence on the risk-benefit of this strategy is lacking 1819 20 21 Indeed, the period after a myocardial infarction is a pathophysiologically vulnerable time, with endothelial dysfunction, elevated inflammatory markers, and so on, and potential rebound effects on these mechanisms of discontinuation of HRT may be more prone to cause adverse cardiovascular events in this period 22…”
Section: Introductionmentioning
confidence: 99%